A live spider was found where they made your injectable semaglutide.

FDA inspectors found it in the compounding room at MedisourceRx — the facility that supplied Hims & Hers. A dead cricket was in the incubator room. A patient who took their product was hospitalized for three nights. They never filed an adverse event report.

FDA Form 483, MedisourceRx LLC, March 2026

He needed a new liver two weeks after starting a compounded weight-loss drug.

A healthy man who just wanted to lose weight was prescribed compounded tirzepatide. Within fourteen days, he was in acute liver failure. He survived because a donor liver was available for emergency transplant.

Washington Post, March 31, 2026

Glass vial with white pharmaceutical powder spilling out against a dramatic black background
17
Deaths linked to compounded GLP-1s
FDA FAERS, December 2024
8,000+
Marylanders sickened by compounded GLP-1s in a single year
Baltimore Sun
1,500%
Increase in poison control calls since 2019
America's Poison Centers
96%
of inspected compounding facilities cited for violations
FDA / Partnership for Safe Medicines

You don't have to take this risk. FDA-approved GLP-1s are now available from $25/month.

Find Legitimate Care →
Pink carrying case containing colorful vials of gray-market peptides alongside orange syringes, arranged on a white surface
“I’m a 68-year-old medical professional, staring at an unmarked glass vial of white powder I paid for in cryptocurrency, about to inject it into myself. What the hell am I doing?”
GLP-1 Forum user, 68-year-old healthcare worker

This is one of 67,000 users on Reddit self-reporting GLP-1 use. 43.5% describe at least one side effect. These are the ones who bothered to post.

“The scariest thing that’s ever happened to me in my life.”

Lottie Moss weighed 110 lbs. She was given a semaglutide dose calibrated for someone over 220 lbs. She seized. Her friend held her feet down until the convulsions stopped. No medical screening. No dosing adjustment. The provider administered twice the maximum safe dose for her body weight.

Documented in public interview; dosing discrepancy confirmed by clinical pharmacologists

Woman sitting on the floor with her head in her hands, a scale and tape measure nearby
The emotional toll of weight-loss drug desperation drives millions toward unregulated sources.

He bought semaglutide from a company called “Swole as F*** Research.” He injected it into 200+ patients without telling them what it was.

Dr. Watkins paid via Venmo. He labeled the payments “meal prep.” The vials said “for lab research only — not for human consumption.” He charged patients for weight-loss consultations and injected them with unverified research chemicals. He made $249,044 in nine months.

DOJ indictment, April 2026; Chinese middleman co-defendant

“I regret my decision to take semaglutide in any form.”

Amy Jenson took compounded semaglutide to lose 10 pounds before her wedding. Her appendix became impacted with fecal matter — a documented but under-discussed GI complication. She had an emergency appendectomy overseas. Ten pounds. An elective cosmetic goal. Emergency surgery in a foreign hospital.

Patient testimony; gastroparesis / GI dysmotility documented in FDA label warnings

Two women received peptide injections at a Las Vegas anti-aging conference. Both left on ventilators.

The doctor who administered the injections wasn’t licensed in Nevada. Two attendees went into respiratory failure at a conference promoting “radical life extension.” The state medical board fined the physician $10,000. Ten thousand dollars for two people on ventilators.

Nevada State Board of Medical Examiners; RAADfest incident reports

Emergency room team rushing a patient on a gurney through hospital corridors, motion blur, blue scrubs
Emergency rooms across the US are treating patients harmed by gray-market GLP-1s.

There's a safer path. Licensed physicians, FDA-approved medications, prices that have collapsed since 2023.

Find Legitimate Care →

We know what the community says. Here's why each argument deserves a second look.

“It’s the same API — my vendor uses the same Chinese lab that supplies Eli Lilly.”
Novo Nordisk documented 19 Chinese companies shipping semaglutide to the US. 12 of the 19 were non-GMP-compliant. The salt forms being sold (semaglutide sodium, tirzepatide sodium) are chemically different molecules that have never been tested in humans. Same factory doesn’t mean same molecule, same purity, or same safety profile.
“I test every batch with Jano. That’s more QC than Walmart does with generics.”
A Janoshik HPLC test confirms identity and purity. It does not test for bacterial endotoxin, sterility, heavy metals, residual solvents, or stereochemistry — the things that actually send people to the ER. The full panel costs $828, and even then, it tests one vial from one batch. Janoshik has no ISO 17025 accreditation. And 43% of everything they tested in 2024 failed purity claims.
“Brand Ozempic is $1,000/month. I can’t afford that.”
In 2023, that was true. In 2026: Wegovy is $349/mo cash ($199 intro). Oral Wegovy is $149/mo. LillyDirect Zepbound is $299/mo. Savings cards drop insured patients to $25/mo. Medicare coverage at $50/mo copay begins mid-2026. The price objection that built the gray market is dying.
“When the vendor disappears, I just find another one.”
When a vendor disappears, so does any possibility of a recall, any product liability claim, and any way to identify what was actually in your last vial. Peptide Sciences — the community’s gold standard — shut down overnight in March 2026. Amino Asylum was raided. Paradigm’s founders are convicted. PeptideElite vanished with $5,000–$10,000 in customer orders. There is no FDIC for research peptides.

Wondering what happens if you actually order? We researched the legal reality — no fear-mongering, just facts. Zero buyers have ever been prosecuted. The real risk isn't legal.

Read the investigation →

The certificate of analysis says 99% pure. The lab results say something else.

Magnifying glass held up to examine a vial of injectable medication, with a syringe in the background
Overhead view of a kitchen counter with a peptide vial, syringe, and bacteriostatic water next to a coffee mug
Gray-market peptides reconstituted on kitchen counters, guided by TikTok tutorials and Reddit threads.

Your “99% pure” semaglutide tested at 7.7% actual content. Endotoxin — bacterial fragments that cause septic shock — was detected in every single sample tested.

Bitar et al., Journal of Medical Internet Research, November 2024

Counterfeit Ozempic pens seized in the US contained insulin instead of semaglutide. Three Americans were hospitalized for hypoglycemia. Their “weight loss drug” was crashing their blood sugar to dangerous levels.

FDA Safety Alert / WHO Rapid Alert, 2024

The FBI documented a medical spa selling “animal grade” semaglutide mixed with vitamin B12. Some products contained no semaglutide at all — just unknown impurities at unknown concentrations.

FBI / Internet Crime Complaint Center (IC3) Public Service Announcement, February 2025

They were the “trusted” ones. They’re all gone.

June 2025
Amino Asylum raided
Federal agents seized inventory. Site went dark overnight. No warning. No refunds.
December 2025
Paradigm Peptides founders plead guilty
Introducing unapproved new drugs into interstate commerce. Sentencing pending.
March 2026
Peptide Sciences shuts down
$7.4M/month in revenue. Three-sentence goodbye. The community’s “gold standard” vanished.
March 2026
Hims’ compounder cited by FDA
Live spider in the production room. Dead cricket in the incubator. Patient hospitalized. No adverse event report filed.
April 2026
Dr. Watkins indicted
200+ patients injected with “lab research only” semaglutide from a Chinese middleman. $249,044 in nine months.
Plain white unmarked mailer package sitting on a kitchen counter, the anonymous arrival of a gray-market peptide order Collage of newspaper clippings and headlines about Ozempic, weight loss drugs, and gray-market peptide dangers Close-up of a vial label reading 'NOT FOR HUMAN CONSUMPTION' next to a syringe, the legal fiction of the gray market

When the vendor disappears, so does any recourse if you’re harmed. There is no FDIC for research peptides.

In 2023, brand Ozempic was $1,000/month. Your only alternative was a $40 Chinese vial.

In 2026, Wegovy is $349/month. Oral Wegovy is $149/month. With a savings card, it’s $25/month.

The price gap that built the gray market has collapsed.
The risk hasn’t.

See the full price comparison
FDA-approved GLP-1 medication boxes — Mounjaro, Wegovy, Ozempic, and Zepbound — displayed on a dark background

These are the FDA-approved medications manufactured under strict quality controls, with known dosing, verified purity, and a chain of custody from factory to pharmacy. They exist. They are increasingly affordable. And they don’t require cryptocurrency or a Telegram broker.

FDA-approved GLP-1s. Licensed physicians. Prices the gray market can’t undercut.

Ro from $199/mo
Hims from $149/mo — now brand Wegovy via Novo partnership
LillyDirect from $299/mo
Compare all providers and insurance options

This isn’t a lecture. It’s a ledger.

Every claim on this site is sourced to peer-reviewed research, FDA filings, DOJ press releases, or court documents. We speak the community’s language because we’ve been in the rooms. We’re not here to moralize — we’re here to make sure you know what’s in your vial before you inject it.

Full research dossier: 200+ primary sources.

Find Legitimate Care →